Tatyana Novoyatleva

Tatyana Novoyatleva

Justus-Liebig-Universität Giessen

H-index: 21

Europe-Germany

About Tatyana Novoyatleva

Tatyana Novoyatleva, With an exceptional h-index of 21 and a recent h-index of 17 (since 2020), a distinguished researcher at Justus-Liebig-Universität Giessen, specializes in the field of Cardiovascular Research, Cardiac Regeneration, Vascular Biology, Pulmonary Hypertension, Cell Cycle.

His recent articles reflect a diverse array of research interests and contributions to the field:

Pulmonary hypertension: new insights and recent advances from basic science to translational approaches

Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension

Mining the plasma proteome for insights into the molecular pathology of pulmonary arterial hypertension

Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2 (vol 4, 1002, 2021)

Adenylate kinase 4—a key regulator of proliferation and metabolic shift in human pulmonary arterial smooth muscle cells via akt and HIF-1α signaling pathways

Impact of PCSK9 on CTRP9-induced metabolic effects in adult rat cardiomyocytes

Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension

Genetic delivery and gene therapy in pulmonary hypertension

Tatyana Novoyatleva Information

University

Position

___

Citations(all)

1718

Citations(since 2020)

853

Cited By

1184

hIndex(all)

21

hIndex(since 2020)

17

i10Index(all)

26

i10Index(since 2020)

23

Email

University Profile Page

Justus-Liebig-Universität Giessen

Google Scholar

View Google Scholar Profile

Tatyana Novoyatleva Skills & Research Interests

Cardiovascular Research

Cardiac Regeneration

Vascular Biology

Pulmonary Hypertension

Cell Cycle

Top articles of Tatyana Novoyatleva

Title

Journal

Author(s)

Publication Date

Pulmonary hypertension: new insights and recent advances from basic science to translational approaches

Tatyana Novoyatleva

2023/5/9

Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension

European Respiratory Journal

Nabham Rai

Akylbek Sydykov

Baktybek Kojonazarov

Jochen Wilhelm

Grégoire Manaud

...

2022/8/1

Mining the plasma proteome for insights into the molecular pathology of pulmonary arterial hypertension

American Journal of Respiratory and Critical Care Medicine

Lars Harbaum

Christopher J Rhodes

John Wharton

Allan Lawrie

Jason H Karnes

...

2022/6/15

Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2 (vol 4, 1002, 2021)

Communications Biology

Tatyana Novoyatleva

Nabham Rai

Baktybek Kojonazarov

Swathi Veeroju

Isabel Ben-Batalla

...

2021/8/24

Adenylate kinase 4—a key regulator of proliferation and metabolic shift in human pulmonary arterial smooth muscle cells via akt and HIF-1α signaling pathways

International journal of molecular sciences

Magdalena Wujak

Christine Veith

Cheng-Yu Wu

Tessa Wilke

Zeki Ilker Kanbagli

...

2021/9/26

Impact of PCSK9 on CTRP9-induced metabolic effects in adult rat cardiomyocytes

Frontiers in Physiology

Susanne Rohrbach

Ling Li

Tatyana Novoyatleva

Bernd Niemann

Fabienne Knapp

...

2021/2/11

Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension

International Journal of Molecular Sciences

Swathi Veeroju

Baktybek Kojonazarov

Astrid Weiss

Hossein Ardeschir Ghofrani

Norbert Weissmann

...

2021/2/2

Genetic delivery and gene therapy in pulmonary hypertension

Nabham Rai

Mazen Shihan

Werner Seeger

Ralph T Schermuly

Tatyana Novoyatleva

2021/1/25

Role of the purinergic P2Y2 receptor in pulmonary hypertension

Mazen Shihan

Tatyana Novoyatleva

Thilo Lehmeyer

Akylbek Sydykov

Ralph T Schermuly

2021/10/20

Axl is a Novel Modulator of Bone Morphogenetic Protein Receptor 2 in pulmonary arterial hypertension

Paul Upton

Tatyana Novoyatleva

Nabham Rai

Baktybek Kojonazarov

Swathi Veeroju

...

2021/10/4

Effect of p53 activation on experimental right ventricular hypertrophy

PloS one

Swathi Veeroju

Argen Mamazhakypov

Nabham Rai

Baktybek Kojonazarov

Valerie Nadeau

...

2020/6/19

Yarsagumba is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties

Medicina

Himal Luitel

Tatyana Novoyatleva

Akylbek Sydykov

Aleksandar Petrovic

Argen Mamazhakypov

...

2020/3/16

IRAG1 Deficient Mice Develop PKG1ß Dependent Pulmonary Hypertension

Siladitta Biswas

Baktybek Kojonazarov

Stefan Hadzic

Michael Majer

Ganimete Bajraktari

...

2020

IRAG1 deficient mice develop PKG1β dependent pulmonary hypertension

Cells

Siladitta Biswas

Baktybek Kojonazarov

Stefan Hadzic

Michael Majer

Ganimete Bajraktari

...

2020/10/13

See List of Professors in Tatyana Novoyatleva University(Justus-Liebig-Universität Giessen)

Co-Authors

H-index: 117
Hossein Ardeschir Ghofrani

Hossein Ardeschir Ghofrani

Justus-Liebig-Universität Giessen

H-index: 72
Liliana Schaefer

Liliana Schaefer

Goethe-Universität Frankfurt am Main

H-index: 71
Mathieu Bollen

Mathieu Bollen

Katholieke Universiteit Leuven

H-index: 62
Riccardo Bellazzi

Riccardo Bellazzi

Università degli Studi di Pavia

H-index: 51
Christian Lorson

Christian Lorson

University of Missouri

H-index: 30
Baktybek Kojonazarov, MD, PhD

Baktybek Kojonazarov, MD, PhD

Justus-Liebig-Universität Giessen

academic-engine